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A B S T R A C T
Valid community-based data on the prevalence of chronic diseases in adolescents (12–18
years) with intellectual disability (ID-adolescents) are scarce. The aim of this study was to
assess the prevalence rates and the nature of chronic diseases in a population of ID-
adolescents and to compare them with the rates among adolescents in the general
population. Therefore, we obtained data on 1083 ID-adolescents attending secondary
schools, day care centers or living in residential centers fully covering one region of the
Netherlands. Parents of the adolescents completed a questionnaire about the occurrence
of chronic diseases in their child during the previous 12 months and about background
characteristics. The questionnaire was derived from the Dutch National Permanent Survey
on Living Conditions questionnaire periodically administered in a representative
population sample (n 10,000). Prevalence rates of chronic diseases in ID-adolescents
were compared with those in adolescents in the Dutch general population. Among ID-
adolescents, high prevalence rates of a wide range of chronic diseases were found. The ﬁve
most prevalent were: ADHD (21.1%), PDD-NOS (14.0%), dyslexia (13.9%), migraine or
chronic headache (12.7%), and autistic disorder (10.9%). These prevalence rates were all
higher (p< 0.05) than among adolescents in the general population. Of all ID-adolescents,
62.9% was reported to have at least one chronic disease. The burden of chronic diseases
among ID-adolescents is very high, showing a high need for adequate care. These high
prevalence rates should alert policymakers and clinicians regarding the widespread of
chronic diseases among ID-adolescents.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
Valid community-based data on the prevalence rates of the full range of chronic diseases in adolescents (12–18 years)
with intellectual disability (ID-adolescents) are scarce (Sawyer, Drew, Yeo, & Britto, 2007; Van Schrojenstein Lantman-de
Valk &Walsh, 2008). A number of studies have reported on the prevalence of speciﬁc chronic diseases in young people with
ID (Airaksinen et al., 2000; Bradley & Bolton, 2006; Bradley & Isaacs, 2006; Bryson, Bradley, Thompson, &Wainwright, 2008;
Cans et al., 1999; Christianson et al., 2002; de Bildt, Sytema, Kraijer, & Minderaa, 2005; Dekker & Koot, 2003; Emerson &
Hatton, 2007; Emerson, 2003; Fernell, 1998; Gothelf et al., 2008; Hou, Wang, & Chuang, 1998; Jelliffe-Pawlowski, Shaw,
Nelson, & Harris, 2003; Koskentausta, Iivanainen, & Almqvist, 2002; Lewis et al., 2000; Magnusson & Saemundsen, 2001;
Merrick &Morag, 2000;Molteno,Molteno, Finchilescu, &Dawes, 2001;Morgan, Baxter, & Kerr, 2003; Nielsen, Skov, & Jensen,* Corresponding author at: University Medical Center Groningen (UMCG), Department of Health Sciences and Graduate School for Health Research
(SHARE), P.O. Box 30.001, 9700 RB Groningen, The Netherlands. Tel.: +31 0 50 363 8914; fax: +31 0 50 363 6251.
E-mail address: b.oeseburg@med.umcg.nl (B. Oeseburg).
Please cite this article in press as: Oeseburg, B., et al. Prevalence of chronic diseases in adolescents with intellectual
disability. Research in Developmental Disabilities (2010), doi:10.1016/j.ridd.2010.01.011
0891-4222/$ – see front matter  2010 Elsevier Ltd. All rights reserved.
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RIDD-870; No. of Pages 72007a; Nielsen, Skov, & Jensen, 2007b; Nordin & Gillberg, 1996; Petterson, Bourke, Leonard, Jacoby, & Bower, 2007;
Steffenburg, Gillberg, & Steffenburg, 1996; Stromme&Diseth, 2000; Stromme&Hagberg, 2000; Van Schrojenstein Lantman-
de Valk, van den Akker, Maaskant, & Haveman, 1997; Voigt, Barbaresi, Colligan, Weaver, & Katusic, 2006; Yeargin-Allsopp,
Murphy, Cordero, Decouﬂe, & Hollowell, 1997; Zhang & Ji, 2005). However, only few studies have reported such prevalence
rates of a wide range of chronic diseases associated with ID (Fernell, 1998; Stromme & Diseth, 2000; Stromme & Hagberg,
2000; Van Schrojenstein Lantman-de Valk et al., 1997). Moreover, only some studies compared their results with the
prevalence rates of chronic diseases in the general population (Emerson & Hatton, 2007; Emerson, 2003; Magnusson &
Saemundsen, 2001; Petterson et al., 2007; Voigt et al., 2006), and none of these studies reported prevalence rates of chronic
diseases among ID-adolescents.
Adolescence is a speciﬁc stage of life between child- and adulthoodwith speciﬁc health needs. It is a time of lifemarked by
physical, emotional, behavioural and social changes, but also by relatively high risks for the onset of (chronic) health
problems (Patton & Viner, 2007; Sawyer et al., 2007; Turk, Graham, & Verhulst, 2007). Literature about young peoplewith ID
suggests that adolescents have a greater risk on chronic diseases compared to adolescents without ID (Cooper, Melville, &
Morrison, 2004; Emerson & Hatton, 2007; Emerson, 2003; Jansen, Krol, Groothoff, & Post, 2004; Kolaitis, 2008;Magnusson &
Saemundsen, 2001; Petterson et al., 2007; Van Schrojenstein Lantman-de Valk & Walsh, 2008; Voigt et al., 2006), but
inclusive data on this are lacking.
Age-speciﬁc community-based data are thus needed to support policymakers and professionals in the adequate provision
and planning of care to ID-adolescents. Policymakers need these data for the planning and ﬁnancing of adequate care
arrangements (e.g. health, education, work) to enhance the well being and societal participation of ID-adolescents and their
families. Professionals need these data to know who are at risk for chronic diseases and to prevent chronic diseases, to
support the early detection and adequate treatment of chronic diseases and their consequences among ID-adolescents and
their families (American Association on Mental Retardation, 2002; Goddard, Davidson, Daly, & Mackey, 2008; McDermott,
Durkin, Schupf, & Stein, 2007; Newacheck, Rising, & Kim, 2006).
The aim of this study is: (1) to assess the prevalence and the nature of chronic diseases in a population of ID-adolescents;




2.1.1. Adolescents with ID
We collected data in 2006–2007 from adolescents with a borderline, mild, moderate, severe or profound ID aged 12–18
years living in two provinces in the north of the Netherlands, Groningen and Drenthe (total population of about 1.1 million
people). Adolescents of the target population attended secondary schools, special secondary schools, day care centers or
lived in residential centers. ID-adolescents attending secondary schools can be classiﬁed as mainly educable and have IQs
between 60 and 84. ID-adolescents attending special secondary schools can be classiﬁed as mainly trainable and have IQs
between 30 and 59. ID-adolescents not attending school, most of them with IQs< 30, attend day care centers or live in
residential centers (Dekker, Koot, van der, & Verhulst, 2002). The target population had been ofﬁcially classiﬁed as having ID
by two independent committees. The Dutch Ministry of Education, Culture and Science established a committee for
adolescents attending secondary or special secondary schools and the Dutch Ministry of Health, Welfare and Sport
established a committee for adolescents attending day care centers or those living in residential centers. The classiﬁcation of
ID is based on the information fromvalidated intelligence tests obtained by both committees (Care Assessment Centre, 2009;
Dutch Eurydice Unit, 2007).
In the current community-based cross-sectional research project, 70% of the schools and centers in both the provinces
participated,with a total of 2271 adolescents. Non-participating schools and centers did not differ fromparticipating schools
and centers with regard to urbanization of the catchment area and number of adolescents. All parents of the 2271
adolescents aged 12–18 years received a questionnaire and a reminder when they did not respond; 1083 parents returned
the questionnaire (48%). Adolescents in the response and non-response group did not differ with regard to age (t-test = 1.86,
p> 0.05), but in the response group girls (x2 = 4.35; p< 0.05) and adolescents with borderline ormild ID (x2 = 8.96; p< 0.05)
were somewhat overrepresented. However, the effect sizes for both the variables were negligible; Cohen’s wwere 0.05 and
0.07, respectively (Cohen, 1988).
The study protocol was approved by the Medical Ethics Committee of the University Medical Center Groningen, the
Netherlands.
2.1.2. Adolescents in the general population
Statistics Netherlands conducts yearly the National Permanent Survey on Living Conditions (POLS) questionnaire in a
representative sample (n 10,000) of the Dutch population (Otten & Winkels, 1998). We used the data, adjusted for non-
response, on adolescents aged 12–18 years in 2007 (Statistics Netherlands, 2009) (response: 64%). Prevalence data on
chronic diseases in adolescents in the general population that were not available via Statistics Netherlands were derived
from the National Institute for Public Health and the Environment (NIPHE). The NIPHE provides national and internationalPlease cite this article in press as: Oeseburg, B., et al. Prevalence of chronic diseases in adolescents with intellectual
disability. Research in Developmental Disabilities (2010), doi:10.1016/j.ridd.2010.01.011
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(National Institute for Public Health and the Environment, 2009).
2.2. Measures
2.2.1. Chronic diseases in ID-adolescents
Chronic diseases in ID-adolescents were measured by the National Permanent Survey on Living Conditions (POLS)
questionnaire;module health and labor, part chronic diseases in children (Statistics Netherlands, 2003). POLS part chronic
diseases in children covers the most prevalent chronic diseases such as ear, eye, skin diseases, diseases of the nervous,
musculoskeletal, blood and circulatory, respiratory, digestive, and endocrine, nutritional and metabolic systems and
attention deﬁcit hyperactivity disorder (ADHD). Questions were added about the presence of pervasive developmental
disorders (PDD). Parents were asked to ﬁll in the presence or absence of each speciﬁc chronic disease in the last 12months
for their child. Parents were also offered the possibility to mention chronic diseases that were not listed in the
questionnaire.
2.2.2. Chronic diseases in adolescents in the general population
The prevalence rates of chronic diseases in adolescents in the general population were measured in the same way as in
our study, using the POLS questionnaire. Prevalence rates of chronic diseases in adolescents in the general population that
were not available in POLS were obtained from the NIPHE. The NIPHE data are based on national and international research
(National Institute for Public Health and the Environment, 2009).
2.2.3. Background characteristics of ID-adolescents
The questionnaire in the ID-adolescents sample comprised questions on age, gender and type of school or institution the
adolescent is attending. We used type of school or institution as a proxy for severity of ID.
2.3. Analysis
First, we computed prevalence rates and the 95% conﬁdence intervals (95%CI) of having one or more chronic diseases,
overall and by type of chronic diseases. The association between the number of chronic diseases and ID severity and gender
were assessed via univariate analysis of variance parameter estimates. Second, we performed multinomial logistic
regression analyses. Odds ratios (OR) and their 95% conﬁdence intervals (95%CI) were computed to assess the association
between the occurrence of chronic diseases by type, and ID severity and gender. Third, we computed prevalence rates of
separate chronic diseases in ID-adolescents, and compared these rates with rates among adolescents in the general
population (12–18 years) (Statistics Netherlands, 2009). We tested differences using chi-square tests. If national data were
not available from Statistics Netherlands, we used data from the NIPHE instead (National Institute for Public Health and the
Environment, 2009). Differences were tested via single proportion tests. For all the differences in proportions, effect sizes
according to Cohenwere calculated (Cohen, 1988). Cohen (1988) deﬁnes an effect sizes of<0.20 as trivial effects; of0.20 to
<0.50 as small effects; of 0.50 to <0.80 as moderate effects; and of 0.80 as large effects.
3. Results
Table 1 shows the background characteristics of the adolescents. The gender ratio, 58.3% boys and 41.7% girls, was similar
to the ratio of boys and girls with ID in the Netherlands (Van Schrojenstein Lantman-de Valk et al., 2002).
Table 2 shows that 63% of the ID-adolescents had at least one chronic disease and 34% had two or more chronic diseases
(mean 1.30; SD 1.47). Thirty-nine per cent of the ID-adolescents had one or more somatic chronic diseases and 41% had one
or more mental chronic diseases. Out of these, 20% had a combination of somatic and mental chronic diseases.Table 1
Demographic characteristics of the sample.
Age in years (N = 1066) Years
Mean (SD) 15.4 (1.6)
Range 12–18
Gender (N = 1074) n (%)
Boys 626 (58.3)
Girls 448 (41.7)
Severity of IDa (N = 1077) n (%)
IQ 60–80 (mild ID) 785 (72.9)
IQ 30–59 (moderate ID) 253 (23.5)
IQ< 30 (severe ID) 39 (3.6)
a Derived from the type of institution at which they were allocated.
Please cite this article in press as: Oeseburg, B., et al. Prevalence of chronic diseases in adolescents with intellectual
disability. Research in Developmental Disabilities (2010), doi:10.1016/j.ridd.2010.01.011
Table 2
Number and type of chronic disease(s) and 95% conﬁdence intervals in ID-adolescents.
ID-adolescents (N = 1083)
n % 95%CI
Number of chronic diseases
0 402 37.1 (34.29; 40.04)
1 313 28.9 (26.28; 31.67)
2 178 16.4 (14.35; 18.77)
3 97 9.0 (7.40; 10.81)
4 56 5.2 (4.00; 6.65)
5–11 37 3.4 (2.49; 4.68)
Type of chronic diseases
None 402 37.1 (34.29; 40.04)
Somatic chronic disease(s) 235 21.7 (19.35; 24.25)
Mental chronic disease(s) 245 22.6 (20.23; 25.21)
Somatic & mental chronic diseases in combination 201 18.6 (16.36; 20.99)
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of chronic diseases, but boys were more likely than girls to be diagnosed with mental chronic diseases (OR 2.23; 95%CI
1.57–3.16) and with a combination of somatic and mental chronic diseases (OR 1.47; 95%CI 1.03–2.10). Severity of ID
was positively associated with the number of chronic diseases (F = 48.12, p< 0.000). With regard to the type of the
chronic diseases, adolescents with severe and moderate ID were more likely than adolescents with mild ID to be
diagnosed with somatic chronic diseases (OR (95%CI) 12.35 (2.70–55.56), and 3.31 (2.04–5.00), respectively), mental
chronic diseases (9.00 (1.91–41.67), and 1.88 (1.22–2.86), respectively) and a combination of somatic and mental
chronic diseases (25.00 (5.62–111.11), and 3.85 (2.56–5.88), respectively). In addition, adolescents with severe ID were
more likely than adolescents with moderate ID to be diagnosed with a combination of somatic and mental chronic
diseases (6.44 (1.43–29.14)).
Table 3 shows that the prevalence rates of chronic diseases among ID-adolescents were statistically signiﬁcant higher for
8 of the 17 chronic diseases compared to the prevalence rates of these chronic diseases in adolescents in the general
population. The effect sizes were negligible for two (asthma, chronic bronchitis and COPD, and psoriasis) of the four somatic
chronic diseases that differed with statistical signiﬁcance, and small for the three other ones (epilepsy, heart diseases, and
blood diseases).With regard tomental chronic diseases, the effect sizes for the statistically signiﬁcant differenceswere small
for dyslexia and medium for ADHD, PDD-NOS and autistic disorder.
4. Discussion
This study shows high prevalence rates of a wide range of chronic diseases in ID-adolescents. For 8 of the 17 chronic
diseases that we assessed the prevalence rates were statistically signiﬁcant higher among ID-adolescents than among in
adolescents in the general population. Differences were particularly large with regard to ADHD, autistic disorder, and PDD-
NOS, and smaller for some somatic diseases. Moreover, differences in prevalence rates were larger if ID was more severe,
with regard to any mental chronic diseases and with regard to a combination of any somatic and any mental chronic
diseases.
4.1. Fit with other studies
Our ﬁndings regarding adolescents cannot be compared with previous ones on adolescents because our study was the
ﬁrst that examined the prevalence rates of a wide range of chronic diseases in ID-adolescents, and compared themwith the
prevalence rates among adolescents in the general population. Previous studies on youth with ID also found higher
prevalence rates of a wide range of mental chronic diseases (Emerson & Hatton, 2007; Emerson, 2003; Magnusson &
Saemundsen, 2001; Voigt et al., 2006) and a wide range of congenital malformations (Petterson et al., 2007) though.
However, these studies did not separately report on adolescents, thus failing to recognize adolescence as a speciﬁc
developmental stage. It is likely that this explain the differences in the prevalence rates of mental chronic diseases and
congenital malformations these studies found compared to our study.
Three factors have been proposed to explain the high rates of chronic diseases in the ID population in general. First
factor is biological/genetic, i.e. genetic and chromosomal disorders that cause both ID and a wide range of chronic
somatic and mental diseases (Dykens, 2000; Emerson & Hatton, 2007; Koskentausta et al., 2002). Second, the
association of ID with socio-economic disadvantage may lead to adverse health outcomes and to higher rates of chronic
diseases (Cooper et al., 2004; Emerson & Hatton, 2007; Emerson & Hatton, 2008; Walsh, 2008). Third, mental chronic
diseases may be associated with ID because they share diagnostic characteristics (Dykens, 2000; Emerson & Hatton,
2007).Please cite this article in press as: Oeseburg, B., et al. Prevalence of chronic diseases in adolescents with intellectual
disability. Research in Developmental Disabilities (2010), doi:10.1016/j.ridd.2010.01.011
Table 3
Prevalence rates of chronic diseases in adolescents with ID and in the general population.
ID-adolescents General population Differences
% n/N % n/N p-Value Cohen’s ha
Somatic chronic diseases
Asthma, chronic bronchitis, COPDb 9.9 107/1083 6.2 30/481 0.019 0.13
Chronic eczemab 4.3 47/1083 2.6 14/536 n.s.c 0.09
Diabetesb 0.5 5/1083 0.4 2/498 n.s. 0.01
Gastrointestinal and liver diseasesb 1.8 19/1083 1.0 4/396 n.s. 0.06
Migraine or chronic headacheb 12.7 138/1083 11.5 52/452 n.s. 0.04
Musculoskeletal diseasesb
Diseases of the backb 2.6 28/1083 2.7 14/517 n.s. 0.01
Inﬂammatory polyarthropathiesb 0.8 9/1083 0.4 2/442 n.s. 0.05
Diseases of neck, shoulder and upper extremitiesb 5.3 57/1083 3.3 14/430 n.s. 0.10
Psoriasisb 1.3 14/1083 0.1 1/519 0.030 0.14
Heart and blood diseasesb 2.4 26/1083 0.1 1/524 0.001 0.22
Congenital malformations circulatory systemd 2.1 23/1083 0.62e – n.s. 0.13
Congenital malformations nervous systemd 2.0 22/1083 0.21e – n.s. 0.19
Epilepsyd 5.3 57/1083 0.27f – 0.000 0.36
95%CI
Somatic chronic diseases no reference data available
Congenital malformations eye 3.0 32/1083 (2.10; 4.14)
Congenital malformations ear 1.8 20/1083 (1.20; 2.84)
Chromosome abnormalities 3.5 38/1083 (2.57; 4.78)
Cerebral palsy 0.5 5/1083 (0.20; 1.07)
Muscular diseases 0.7 8/1083 (0.38; 1.45)
Other congenital malformations 6.1 66/1083 (4.81; 7.68)
Other somatic disorders 3.7 40/1083 (2.72; 4.99)
% n/N % n/N p-Value Cohen’s ha
Mental chronic diseases
Dyslexiab 13.9 151/1083 3.8g 87/2285 0.000 0.37
Attention deﬁcit/hyperactivity disorder (ADHD)d 21.1 229/1083 1.3h – 0.000 0.73
Autistic disorderd 10.9 118/1083 0.1i – 0.000 0.61
Pervasive developmental disorder not otherwise speciﬁed (PDD-NOS)d 14.0 152/1083 0.2i – 0.000 0.68
95%CI
Mental chronic diseases no reference data available
Other psychiatric disorders 1.8 19/1083 (1.12; 2.72)
Bold results are statistically signiﬁcant.
a Cohen thresholds: negligible effect (0.20); small effect (0.20 and <0.50); medium effect (0.50 and <0.80); large effect (0.80).
b Reference data on adolescents aged 12–18 from Statistics Netherlands (POLS).
c Not signiﬁcant.
d Reference data from the National Institute for Public Health and the Environment.
e Only data at birth available.
f Only data on the age-group 15–24 years available.
g Only data on the age-group 4–12 years available.
h Only data on the age-group 13–17 years available.
i Prevalence data estimated on the basis of the review of Fombonne (2005) on autistic disorder and other pervasive developmental disorders.
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Important strengths of this study are that it examined the prevalence rates of a wide range of chronic diseases in ID-
adolescents in a community-based sample representative for about 90% of the adolescents with ID, and compared most
outcomes with similarly obtained data on adolescents without ID. A limitation may be that data collection procedures may
have slightly differed between adolescents with ID and in the general population. POLS did not cover mental disorders other
than ADHD, we used data of the NIPHE instead. However, the differences in prevalence rates were so large that they are
unlikely to be fully explained by methodological differences. A second limitation is the relatively low response rate of our
study (48%). This could lead to selection bias, but non-response analyses revealed no major differences with regard to age,
gender and educational level.
4.3. Implications
We found disconcertingly high prevalence rates for some chronic diseases among ID-adolescents which should alert
policymakers and clinicians to these diseases among ID-adolescents. This shows a need for effective care arrangements to
handle this huge burden ofmorbidity, bothwith regard to its prevention and its treatment. As such, it provides a challenge toPlease cite this article in press as: Oeseburg, B., et al. Prevalence of chronic diseases in adolescents with intellectual
disability. Research in Developmental Disabilities (2010), doi:10.1016/j.ridd.2010.01.011
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Newacheck et al., 2006).
Our study is the ﬁrst to examine the prevalence rates of a wide range of chronic diseases in ID-adolescents and
compare the results with data on adolescents without ID. Therefore, our ﬁndings need conﬁrmation, including an
assessment of the pathways leading to such high prevalence rates. Anyhow, our results show a very high burden of
chronic diseases among ID-adolescents, and thus adequate care is highly needed (Cooper et al., 2004; Van Schrojenstein
Lantman-de Valk & Walsh, 2008).
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